Latest Morning Briefing Stories
Journalists Wrap Up 2024 With Topics From Trump 2.0 to Frustration With Health Industry
KFF Health News staff made the rounds on national and local media in the last two weeks to discuss topical stories. Here’s a collection of their appearances.
‘Bill of the Month’: The Series That Dissects and Slashes Medical Bills
Since 2018, readers and listeners sent KFF Health News-NPR’s “Bill of the Month” thousands of questionable bills. Our crowdsourced investigation paved the way for landmark legislation and highlighted cost-saving strategies for all patients.
Employers Press Congress To Cement Health Price Transparency Before Trump’s Return
Donald Trump’s first administration advanced rules forcing hospitals and insurers to reveal prices for medical services. Employers don’t want to risk backtracking during Trump’s second administration.
Readers Offer ‘Solo Agers’ Support and Reflect on Ancestors
KFF Health News gives readers a chance to comment on a recent batch of stories.
Federal ACA Marketplace Enrollment Lagging
It’s open enrollment season for the Affordable Care Act — and there are ongoing challenges. First up, enrollment. New and returning sign-ups through healthcare.gov — the federal marketplace that serves 31 states — are well below last year’s rate. New enrollments were just over 730,000 in early December, compared with 1.5 million at the same time last year. To give consumers in those states more time to […]
He Went in for a Colonoscopy. The Hospital Charged $19,000 for Two.
A man in Chicago with a troubling symptom underwent a common procedure. Then he wanted to know why the hospital charged nearly three times its own cost estimate.
Obamacare Sign-Ups Lag After Trump Election, Legal Challenges
The number of new and returning enrollees using healthcare.gov — the federal marketplace that serves 31 states — is well below last year’s as of early December. Also, a Biden administration push to give “Dreamers” access to Obamacare coverage and subsidies is facing court challenges.
Democratic Senators Ask Watchdog Agency To Investigate Georgia’s Medicaid Work Rule
A group of Democratic senators asked the Government Accountability Office to examine a Georgia program that requires some Medicaid enrollees to work, study, or volunteer 80 hours a month for coverage. They cited KFF Health News’ reporting, which has documented the program’s high costs and low enrollment.
How a Duty To Spend Wisely on Worker Benefits Could Loosen PBMs’ Grip on Drug Prices
As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” PBMs — or force them to change.
Rage Has Long Shadowed American Health Care. It’s Rarely Produced Big Change.
The outpouring of anger at health insurers following the killing of UnitedHealthcare CEO Brian Thompson continues a cycle of rage that dates back decades.
Native American Patients Are Sent to Collections for Debts the Government Owes
Federal law says Native Americans aren’t liable for medical bills the Indian Health Service promises to pay. Some are billed anyway as a result of backlogs or mistakes from the agency, financial middlemen, or health systems.
Removing a Splinter? Treating a Wart? If a Doctor Does It, It Can Be Billed as Surgery
Minor interventions are increasingly being rebranded and billed as surgery, for profit. This means a neurologist spending 40 minutes with a patient to tease out a diagnosis can be paid less for that time than a dermatologist spending a few seconds squirting a dollop of liquid nitrogen onto the skin.
KFF Health News' 'What the Health?': A Killing Touches Off Backlash Against Health Insurers
The shocking shooting death of UnitedHealthcare’s chief executive in Midtown Manhattan prompted a public outcry about the problems with the nation’s health care system, as stories of delayed and denied care filled social media. Meanwhile, President-elect Donald Trump continues to avoid providing specifics about his plans for the Affordable Care Act and other health issues. Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Rachel Cohrs Zhang of Stat join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Francis Collins, who was the director of the National Institutes of Health and a science adviser to President Joe Biden.
Florida’s Canada Drug Importation Plan Has Yet to Launch
Florida Gov. Ron DeSantis (R)spent years complaining that the Biden administration was slow-walking federal approval of his plan to import lower-cost prescription drugs from Canada — a concept endorsed by Donald Trump in 2020 just before his first presidential term ended. But nearly a year since the Food and Drug Administration green-lit the state’s importation […]
An Arm and a Leg: New Lessons in the Fight for Charity Care
Host Dan Weissmann checks back in on the fight for hospital charity care, with lessons from Dollar For and a savvy listener.
9 States Poised To End Coverage for Millions if Trump Cuts Medicaid Funding
About 3.7 million people are at immediate risk of losing health coverage should the federal government cut funding for Medicaid expansions, as some allies of President-elect Donald Trump have proposed. Coverage could be at risk in the 40 states that have expanded Medicaid.
With Trump on the Way, Advocates Look to States To Pick Up Medical Debt Fight
Patient and consumer advocates fear a new Trump administration will scale back federal efforts to expand financial protections for patients and shield them from debt.
Who Gets Obesity Drugs Covered by Insurance? In North Carolina, It Helps If You’re on Medicaid
GLP-1 agonist medications such as Ozempic accounted for 10% of the North Carolina state employee health plan’s prescription drug spending, so the state is no longer covering them for weight loss alone. Still, it did decide to cover them for Medicaid patients’ weight loss. A look inside the state’s coverage calculus.
¿Podrían los nuevos medicamentos para bajar de peso estar disponibles para todos?
Los medicamentos agonistas GLP-1, conocidos por los nombres comerciales Ozempic, Trulicity y Wegovy, han demostrado ser efectivos para la pérdida de peso y para el manejo de la diabetes tipo 2.
A Toddler Got a Nasal Swab Test but Left Before Seeing a Doctor. The Bill Was $445.
A mom in Peoria, Illinois, took her 3-year-old to the ER one evening last December. While they were waiting to be seen, the toddler seemed better, so they left without seeing a doctor. Then the bill came.
